Myosin light chain phosphorylation in human myometrial smooth muscle cells

L. W. MacKenzie, R. A. Word, M. L. Casey, J. T. Stull

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Ca2+/calmodulin-dependent phosphorylation of the 20-kDa regulatory light chain of myosin is of signal importance in the initiation of contraction in a number of smooth muscle tissues. In this investigation, we evaluated the relationship between intracellular free Ca2+ concentration ([Ca2+](i)) and the extent of myosin light chain phosphorylation in cultured human myometrial smooth muscle cells. Treatment of myometrial cells with ionomycin caused a concentration- and time-dependent increase in [Ca2+](i) and phosphorylation of myosin light chain. Temporally, the increases in light chain phosphorylation and [Ca2+](i) in response to ionomycin were similar. In myometrial cells treated with ionomycin (10-5 M) for 10 s, [Ca2+](i) increased from 138 to 800 nM; in these same cells, myosin light chain phosphorylation increased from 5% to a maximum value of 54%. Half-maximal phosphorylation of myosin light chain was attained at 300 nM [Ca2+](i). Treatment of myometrial smooth muscle cells with prostaglandin (PG) F(2α) (10-8 M) and PGE2 (10-8 M) caused a proportionate increase in [Ca2+](i) and myosin light chain phosphorylation. In addition, [Ca2+](i) and myosin light chain phosphorylation increased in response to oxytocin and angiotensin II. These findings indicate that a number of uterotonic agents effect an increase in [Ca2+](i), which in turn causes phosphorylation of myosin light chain. Furthermore, the concentration of Ca2+ in the cytoplasm is a primary determinant for myosin light chain phosphorylation in human myometrial smooth muscle cells.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Cell Physiology
Volume258
Issue number1 27-1
StatePublished - 1990

Fingerprint

Myosin Light Chains
Phosphorylation
Smooth Muscle Myocytes
Muscle
Cells
Ionomycin
Prostaglandins F
Oxytocin
Calmodulin
Angiotensin II
Smooth Muscle
Cytoplasm
Tissue
Light
Muscles

Keywords

  • angiotensin II
  • fura-2
  • ionomycin
  • oxytocin
  • prostaglandins

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Myosin light chain phosphorylation in human myometrial smooth muscle cells. / MacKenzie, L. W.; Word, R. A.; Casey, M. L.; Stull, J. T.

In: American Journal of Physiology - Cell Physiology, Vol. 258, No. 1 27-1, 1990.

Research output: Contribution to journalArticle

@article{fb17eac1d2c04c8e8c899956e4a6790f,
title = "Myosin light chain phosphorylation in human myometrial smooth muscle cells",
abstract = "Ca2+/calmodulin-dependent phosphorylation of the 20-kDa regulatory light chain of myosin is of signal importance in the initiation of contraction in a number of smooth muscle tissues. In this investigation, we evaluated the relationship between intracellular free Ca2+ concentration ([Ca2+](i)) and the extent of myosin light chain phosphorylation in cultured human myometrial smooth muscle cells. Treatment of myometrial cells with ionomycin caused a concentration- and time-dependent increase in [Ca2+](i) and phosphorylation of myosin light chain. Temporally, the increases in light chain phosphorylation and [Ca2+](i) in response to ionomycin were similar. In myometrial cells treated with ionomycin (10-5 M) for 10 s, [Ca2+](i) increased from 138 to 800 nM; in these same cells, myosin light chain phosphorylation increased from 5{\%} to a maximum value of 54{\%}. Half-maximal phosphorylation of myosin light chain was attained at 300 nM [Ca2+](i). Treatment of myometrial smooth muscle cells with prostaglandin (PG) F(2α) (10-8 M) and PGE2 (10-8 M) caused a proportionate increase in [Ca2+](i) and myosin light chain phosphorylation. In addition, [Ca2+](i) and myosin light chain phosphorylation increased in response to oxytocin and angiotensin II. These findings indicate that a number of uterotonic agents effect an increase in [Ca2+](i), which in turn causes phosphorylation of myosin light chain. Furthermore, the concentration of Ca2+ in the cytoplasm is a primary determinant for myosin light chain phosphorylation in human myometrial smooth muscle cells.",
keywords = "angiotensin II, fura-2, ionomycin, oxytocin, prostaglandins",
author = "MacKenzie, {L. W.} and Word, {R. A.} and Casey, {M. L.} and Stull, {J. T.}",
year = "1990",
language = "English (US)",
volume = "258",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 27-1",

}

TY - JOUR

T1 - Myosin light chain phosphorylation in human myometrial smooth muscle cells

AU - MacKenzie, L. W.

AU - Word, R. A.

AU - Casey, M. L.

AU - Stull, J. T.

PY - 1990

Y1 - 1990

N2 - Ca2+/calmodulin-dependent phosphorylation of the 20-kDa regulatory light chain of myosin is of signal importance in the initiation of contraction in a number of smooth muscle tissues. In this investigation, we evaluated the relationship between intracellular free Ca2+ concentration ([Ca2+](i)) and the extent of myosin light chain phosphorylation in cultured human myometrial smooth muscle cells. Treatment of myometrial cells with ionomycin caused a concentration- and time-dependent increase in [Ca2+](i) and phosphorylation of myosin light chain. Temporally, the increases in light chain phosphorylation and [Ca2+](i) in response to ionomycin were similar. In myometrial cells treated with ionomycin (10-5 M) for 10 s, [Ca2+](i) increased from 138 to 800 nM; in these same cells, myosin light chain phosphorylation increased from 5% to a maximum value of 54%. Half-maximal phosphorylation of myosin light chain was attained at 300 nM [Ca2+](i). Treatment of myometrial smooth muscle cells with prostaglandin (PG) F(2α) (10-8 M) and PGE2 (10-8 M) caused a proportionate increase in [Ca2+](i) and myosin light chain phosphorylation. In addition, [Ca2+](i) and myosin light chain phosphorylation increased in response to oxytocin and angiotensin II. These findings indicate that a number of uterotonic agents effect an increase in [Ca2+](i), which in turn causes phosphorylation of myosin light chain. Furthermore, the concentration of Ca2+ in the cytoplasm is a primary determinant for myosin light chain phosphorylation in human myometrial smooth muscle cells.

AB - Ca2+/calmodulin-dependent phosphorylation of the 20-kDa regulatory light chain of myosin is of signal importance in the initiation of contraction in a number of smooth muscle tissues. In this investigation, we evaluated the relationship between intracellular free Ca2+ concentration ([Ca2+](i)) and the extent of myosin light chain phosphorylation in cultured human myometrial smooth muscle cells. Treatment of myometrial cells with ionomycin caused a concentration- and time-dependent increase in [Ca2+](i) and phosphorylation of myosin light chain. Temporally, the increases in light chain phosphorylation and [Ca2+](i) in response to ionomycin were similar. In myometrial cells treated with ionomycin (10-5 M) for 10 s, [Ca2+](i) increased from 138 to 800 nM; in these same cells, myosin light chain phosphorylation increased from 5% to a maximum value of 54%. Half-maximal phosphorylation of myosin light chain was attained at 300 nM [Ca2+](i). Treatment of myometrial smooth muscle cells with prostaglandin (PG) F(2α) (10-8 M) and PGE2 (10-8 M) caused a proportionate increase in [Ca2+](i) and myosin light chain phosphorylation. In addition, [Ca2+](i) and myosin light chain phosphorylation increased in response to oxytocin and angiotensin II. These findings indicate that a number of uterotonic agents effect an increase in [Ca2+](i), which in turn causes phosphorylation of myosin light chain. Furthermore, the concentration of Ca2+ in the cytoplasm is a primary determinant for myosin light chain phosphorylation in human myometrial smooth muscle cells.

KW - angiotensin II

KW - fura-2

KW - ionomycin

KW - oxytocin

KW - prostaglandins

UR - http://www.scopus.com/inward/record.url?scp=0025073246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025073246&partnerID=8YFLogxK

M3 - Article

C2 - 2301567

AN - SCOPUS:0025073246

VL - 258

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1 27-1

ER -